Amneal Pharmaceuticals Inc.
AMRX | NASDAQ
$19.20
-$0.96 (-4.76%)
Sep 22, 2026, 1:21 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.12B | 3.05B | 3.02B | 2.93B | 2.85B | 2.83B | 2.79B | 2.68B | 2.6B | 2.5B | 2.39B | 2.39B | 2.31B | 2.27B | 2.21B | 2.14B | 2.12B | 2.1B | 2.09B | 2.07B | 2.06B | 1.99B |
Cost of Revenue | 1.89B | 1.87B | 1.91B | 1.86B | 1.78B | 1.79B | 1.77B | 1.7B | 1.65B | 1.58B | 1.54B | 1.54B | 1.5B | 1.48B | 1.43B | 1.4B | 1.38B | 1.35B | 1.32B | 1.3B | 1.35B | 1.35B |
Gross Profit | 1.23B | 1.18B | 1.11B | 1.08B | 1.07B | 1.04B | 1.02B | 983.05M | 946.02M | 916.09M | 856.22M | 846.13M | 807.83M | 788.32M | 784.71M | 735.72M | 740M | 751.98M | 768.97M | 769.64M | 704.72M | 636.46M |
Operating Income | 246.62M | 359.29M | 326.1M | 287.4M | 376.32M | 360.42M | 249.33M | 187.73M | 174.57M | 159.18M | 204.37M | 226.21M | 194.92M | -83.78M | -94.93M | -119.79M | -135.62M | 130.11M | 152.72M | 161.72M | 135.64M | 79.27M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 201.18M | 181.9M | 139.21M | 68.66M | 89.3M | 58M | -55.01M | -123.16M | -115.62M | -106.37M | -40.27M | 35.54M | 14.76M | -247.63M | -248.13M | -256.79M | -261.01M | 6.54M | 31.37M | 42.21M | 22.36M | -34.22M |
Net Income | 157.6M | 122.36M | 72.06M | 5.9M | 3.38M | -13.05M | -116.89M | -184.45M | -174.62M | -168.69M | -83.99M | 10.32M | -2.05M | -134.77M | -129.99M | -132.03M | -133.58M | 1.76M | 10.62M | 13.96M | 9.23M | -17.3M |
Selling & General & Admin | 619.57M | 595.12M | 526.83M | 509.06M | 489.93M | 482.13M | 476.44M | 456.75M | 451.07M | 440.17M | 429.68M | 422.83M | 409.9M | 403.13M | 399.7M | 394.77M | 386.09M | 373.44M | 365.5M | 352.97M | 344.69M | 339.48M |
Research & Development | 175.57M | 186.54M | 189.96M | 211.26M | 209M | 196.12M | 193.61M | 184.06M | 165.22M | 166.74M | 167.78M | 164.48M | 173.87M | 186.82M | 200.05M | 209.79M | 208.7M | 211.36M | 209.56M | 213.71M | 209.81M | 204.7M |
Other Expenses | 35.95M | 36.59M | 70.42M | 71.28M | -681K | -396K | 101.07M | 154.51M | 155.17M | 150M | 54.39M | 32.6M | 29.14M | 282.16M | 279.89M | 250.95M | 280.83M | 37.06M | 41.19M | 41.25M | 14.58M | 13.01M |
Operating Expenses | 831.09M | 818.24M | 787.2M | 791.6M | 698.25M | 677.85M | 771.11M | 795.32M | 771.45M | 756.91M | 651.85M | 619.91M | 612.91M | 872.11M | 879.64M | 855.51M | 875.63M | 621.87M | 616.26M | 607.92M | 569.08M | 557.19M |
Interest Expense | 117.37M | 237.51M | 241.09M | 246.52M | 249.21M | 249.83M | 258.6M | 256.48M | 241.88M | 227.02M | 210.63M | 198.11M | 189.59M | 174.36M | 158.38M | 145.31M | 137.32M | 135.78M | 136.33M | 136.9M | 137.4M | 139.98M |
Selling & Marketing Expenses | n/a | n/a | n/a | 34.4M | 34.4M | 34.4M | 34.4M | 12.4M | 12.4M | 12.4M | 12.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.72B | 2.69B | 2.69B | 2.65B | 2.48B | 2.47B | 2.54B | 2.49B | 2.42B | 2.34B | 2.19B | 2.16B | 2.12B | 2.36B | 2.31B | 2.26B | 2.26B | 1.97B | 1.94B | 1.91B | 1.92B | 1.91B |
Income Tax Expense | -14.14M | 584K | 11.28M | 11.04M | 38.06M | 25.58M | 18.86M | 23.32M | 17.58M | 13.94M | 8.45M | -3.23M | 3.42M | 10.79M | 6.66M | 12.6M | 12.08M | 7.38M | 11.2M | 8.54M | 4.64M | 4.17M |
Shares Outstanding (Basic) | 319.2M | 328.93M | 313.37M | 314.17M | 313.74M | 311.05M | 309.85M | 309.65M | 309.12M | 305.48M | 243.71M | 161.37M | 153.74M | 152.11M | 151.48M | 151.39M | 150.99M | 149.89M | 149.37M | 149.29M | 149M | 148.01M |
Shares Outstanding (Diluted) | 328.1M | 328.93M | 324.81M | 324.75M | 322.36M | 323.96M | 309.85M | 309.65M | 318.96M | 307.28M | 243.71M | 159.69M | 154.89M | 152.11M | 151.48M | 151.39M | 150.99M | 149.89M | 149.37M | 149.29M | 151.99M | 151.22M |
EPS (Basic) | 0.49 | 0.38 | 0.23 | 0.02 | 0.01 | -0.04 | -0.38 | -0.68 | -0.62 | -0.56 | -0.33 | 0.03 | -0.04 | -0.92 | -0.90 | -0.90 | -0.91 | -0.01 | 0.08 | 0.10 | 0.07 | -0.11 |
EPS (Diluted) | 0.49 | 0.38 | 0.22 | 0.01 | 0.01 | -0.04 | -0.38 | -0.68 | -0.62 | -0.56 | -0.33 | 0.03 | -0.04 | -0.92 | -0.90 | -0.90 | -0.91 | -0.01 | 0.07 | 0.09 | 0.06 | -0.12 |
EBITDA | 447.79M | 626.02M | 603.87M | 555.65M | 583.88M | 548.65M | 439.77M | 360.32M | 351.5M | 347.43M | 399.76M | 467.17M | 442.28M | 167.24M | 150.43M | 128.82M | 115.18M | 377.99M | 401.1M | 411.21M | 391.03M | 338.62M |
EBIT | 302.6M | 419.41M | 380.3M | 315.17M | 338.51M | 307.83M | 203.58M | 133.33M | 126.26M | 120.65M | 170.36M | 233.65M | 204.35M | -73.28M | -89.75M | -111.49M | -123.7M | 142.32M | 167.69M | 179.11M | 159.76M | 105.76M |
Depreciation & Amortization | 146.49M | 206.6M | 223.57M | 240.48M | 245.36M | 240.82M | 236.19M | 226.99M | 225.24M | 226.78M | 229.4M | 233.52M | 237.93M | 240.51M | 240.18M | 240.3M | 238.88M | 235.67M | 233.41M | 232.1M | 231.27M | 232.85M |
Add to Watchlist
Select watchlists to add or remove AMRX